Background: Studies have questioned the downward trend in mortality from cardiovascular diseases (CVD) in Brazil in recent years.
Introduction
Cardiovascular diseases (CVD) are the main cause of death in the Brazilian population. 1, 2 CVDs are responsible for at least 20% of deaths in our population over 30 years old. In the South and Southeast regions of the country, the rate of mortality from CVD was even greater than in other regions. 3 Previous studies have shown consistent data about the downward trend in the mortality rate from CVD in Brazil. 4, 5 Deaths by cerebrovascular diseases (CBVD) had greater reduction in mortality rate when compared to ischemic heart disease (IHD). 4 A recent update in CVD mortality data in Brazil and in the metropolitan region of São Paulo showed a downward trend in the rate of mortality from IHD and CBVD between 1990 and 2009. 2 In Brazil, starting in 1987, deaths from IHD were, in men, higher than deaths from CBVD. In women, however, this difference was only noticed as of 1999. Both causes of death showed a downward trend in the period of 1980 -2009, but this trend was more evident in deaths from CBVD. However, in men, from 2007 to 2009, the mortality rate adjusted by age from IHD remained unaltered. Nevertheless, due to the period of only three years, it was not possible to establish a real trend in mortality. This study updated the rate of mortality from cardiovascular diseases in Brazil until 2012. Trends in rate of mortality from CVD, IHD and CBVD in the period of 2007-2012 were also analysed and compared to previous years. 6 Simple linear regression was used to analyse the temporal evolution of mortality rate associated to CVD, IHD, and CBVD, followed by the comparison of slopes of regression lines. The level of significance was p < 0.05. The statistical software used was Primer of Biostatistics, version 4.02.9. Table 2 .
Methods

Rates
The annual alterations in mortality for the periods of 1980-2007 and 2007-2012 were respectively: CVD total: -1.5% e -0.8%, CVD men: -1.4% e -0.6%, CVD women: -1.7% e -1.0%, IHD total: -0.90% e -0.08%, IHD men: -1.1% e 0.1%, IHD women: -1.5% e -0.4%, CBVD total: -1.26% e -1.60%, CBVD men: -1.7% e -1.4% and CBVD women: -2.0% e -1.9%. 
Discussion
This study showed a trend in the reduction of mortality from cardiovascular diseases from 1980 to 2012, but in the analysis of the period of 2007-2012 no reduction in mortality from IHD was observed in men or women.
Studies showed a trend in the reduction of mortality from cardiovascular diseases in several countries, especially in the more developed countries of Western Europe, USA, and Canada. [8] [9] [10] A recent update showed significant reduction in mortality from CVDs in all states of the USA. 10 However, only a small reduction in mortality from IHD was observed in young adults, especially women. 11 Despite the significant discrepancies between death rates from CVD in Europe, many European countries also had an increase or small reduction in mortality from CVD. 12 Control of the risk factor, and improvements in clinical and interventional treatments are the main justifications for the reduction in mortality in more developed countries. 13, 14 Just as in our study, a reduction of mortality from such diseases was also observed in developing countries. 15 Even with population changes in these countries, such as increase and aging of the population, the trends in mortality from CVD have been maintained with the adjustment of the coefficient for age, gender and specific disease (IHD or CBVD). 9 Our study showed significant and constant reduction in the mortality from CBVD in the period of 1980 to 2012. This was, most likely, due to an increased facility in diagnosis and treatment of the main risk factor for such diseases -the systemic arterial hypertension (SAH). In 2013, the diagnosis of SAH was 21.2% for the population over 18 years old and >50% for individuals over 65 years old. Almost 70% of these patients with SAH had some kind of medical assistance and 36% took at least one medication for hypertension in the Brazilian government program Programa Farmácia Popular (Popular Pharmacy Program). 16 On the other hand, the complexity of the factors involved in the pathophysiology of the atherosclerosis process largely increases the challenge of preventing IHDs. SAH control has great impact on the morbidity and mortality of CBVDs, while diagnosis and treatment of IHDs involve other risk factors, such as dyslipidemia, smoking, and diabetes, many times unknown until the first coronary event. Associated to the complexity of clinical treatment, there is the limited availability of interventional treatment, restricted to large urban centers. The result is the big heterogeneity of the risk of death from acute myocardial infarction in the different regions of Brazil. 17 However, in the period between 2007 and 2012, the justifications for a halt in the downward trend in mortality from IHD are unknown. Socioeconomic aspects and decreased access to adequate healthcare system by the less privileged population for diagnosis and treatment of IHDs may 1994  532  609  455  151  151  187  170  116  132   1995  524  591  457  152  147  184  165  119  130   1996  477  543  411  143  129  176  145  110  114   1997  472  538  407  141  130  173  147  109  113   1998  481  550  411  144  131  177  149  110  112   1999  478  546  411  144  127  178  144  111  110   2000  423  491  356  130  111  162  127  97  95   2001  423  492  354  130  113  162  130  97  95   2002  426  491  360  132  113  164  130  99  97   2003  433  503  362  133  113  167  131  100  96   2004  447  519  375  138  114  172  131  103  97   2005  434  503  365  132  111  165  126  98  96   2006  458  530  386  139  119  174  136  103  103   2007  391  457  325  120  99  151  115  88  84   2008  391  458  324  120  98  153  114  88  83   2009  380  446  315  117  95  149  110  85  81   2010  370  438  302  116  92  148  107  83  76   2011  377  445  309  119  92  152  108  86  76   2012  372  440  305  119  90  152  105  86  75   %var  -41  -38  -46  -34  -49  -31  -45  - be impacting on the change observed in the trend of mortality from such diseases. Baena et al. 18 have shown an increase in mortality from IHD in the North and Northeast regions, which are known to be underprivileged in Brazil. In mortality from CVD, [19] [20] [21] [22] studies have also shown the significance of social inequalities and discrepancies in level of education of the population. Half of the causes of death from CVD, before 65 years of age, can be attributed to poverty. Likewise, low levels of education contribute to poverty, which further increases the rate of mortality from CVD. Malnourishment, little physical activity, alcohol consumption and smoking are other important risk factors for CVD, and are more prevalent in less privileged layers of the population. 23, 24 Therefore, the institution of public policies of prevention of CVD should be intensified to reinstate a downward 
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trend in mortality from CVD. Environmental, occupational, behavioral and metabolic factors were responsible for almost 90% of disability-adjusted life years (DALYs) and deaths from CVD. 25 The limitations of this study relate to the quality of the Brazilian data about mortality, such as errors related to diagnosis and precision of death certificates, deaths associated with unknown causes and data entry errors. The number of death certificates containing a diagnosis for the cause of death, such as poorly defined symptoms, signs and health conditions is an indirect indicator of the standard quality of data. These certificates, despite progressive improvement, are still significant in the Northeast, north and Midwest regions in Brazil, but not in the South or Southeast. [26] [27] Validation studies for the data about mortality are not available in the majority of states and cities in Brazil.
Conclusion
As opposed to CBVD, the trend in mortality from IHD stopped going down in Brazil in the last six years. It is necessary to intensify healthcare policies about the control of the main risk factors so as to reinstate the downward trend in mortality rate from IHD. 
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